EU Seeks Info On Drug Patent Deals From 2010
The European Commission has asked pharmaceutical companies for details on patent settlements with generic-drug makers completed in 2010, continuing a probe into deals that may have delayed the entry of cheaper...To view the full article, register now.
Already a subscriber? Click here to view full article